C.S. Mott Children's Hospital

C.S. Mott Children's Hospital made it into the next round of STAT Madness and we need your help to advance! Please vote for Mott in the bracket before Saturday: https://lnkd.in/e5SDKQKC The Mott team selected for this competition led research finding a link between a viral infection contracted in utero and autism. The work was supported by funding from the National Institutes of Health.

Do you feel like you know the risks and facts surrounding bird flu? What parents say in our new national poll: michmed.org/zg8QV

Meet Everly one of our Little Victors from our 2025 calendar. “Our sweet Everly has shown true strength and resilience since birth. Our family was unaware of her heart defect in utero, but Mom ended up having a STAT c-section and Everly spent 72 hours on a cooling blanket due to lack of oxygen because the cord was wrapped around her neck. Shortly after, her MRI showed good results, and we were cleared to go home. Just before going home, we found out that Everly had a heart defect called truncus arteriosus. She was transported to Mott at 9 days of life for an open-heart surgery and is now thriving!! Everly has never let any obstacle get in her way and she is crushing all of her milestones. She is the most beautiful baby and toughest heart warrior. She puts a smile on all of the faces around her. We love you Everly Mae!! Our care from everyone at Mott was second to none. Every nurse, doctor, technician, and staff member were so compassionate, helpful, and loving during the toughest month of our lives. We were able to rest more easily knowing that our sweet girl was in the best care possible and that the staff was willing to go above and beyond to provide her with exceptional care. We will forever be grateful for the quality care our sweet Everly received at Mott Children's Hospital.” Hail, Everly!

A new clinical trial will allow Michigan Medicine researchers to study 3D-printed bioresorbable devices aimed at treating children with rare and life-threatening airway condition tracheobronchomalacia. The trial, launched by Michigan Medicine and Materialise, marks a crucial step towards full FDA approval for the innovative devices designed to support the airways of infants with the severest forms of the disease. Tracheobronchomalacia causes the airway to collapse, making breathing difficult and, in severe cases, can be fatal. Currently, infants with this condition often rely on ventilators to survive. “We have established a process that allows us to offer the customized airway splint as a last resort treatment for certain children with no other options but we need more research to make it available on a wider scale,” said trial principal investigator Richard Ohye, M.D., a pediatric heart surgeon at U-M Health C.S. Mott Children’s Hospital, who leads surgical implantation of the device. “We needed a revolutionary innovation to give these babies a chance to survive,” said Mott otolaryngology surgeon Glenn Green, M.D., one of the inventors of the device. Learn more: https://lnkd.in/e6wP9NPi

Meet Gavin one of our Little Victors from our 2025 calendar. “Gavin is 10 years old and has cerebral palsy. He has lived with physical challenges all his life. In addition, he also has autism, anxiety, and ADHD, leading to not only having physical difficulties, but also behavioral and mental health difficulties. Mott's neuro team has supported his cerebral palsy, and the behavioral health team entered our lives after Gavin was experiencing significant mental health and behavioral concerns when he turned 9 years old. After several medication trials, emergency room visits and admissions, the team never gave up. After many months, he finally has a medication combination that allows him to be the happy, sweet, loving boy that he is. We are forever thankful for their efforts to give us our son back so he can truly live life! We are forever grateful for Dr. Ince from behavioral health. He never gave up on Gavin, was available and responsive when we were needing to go to the emergency room, and coordinated care while Gavin was admitted to Mott. He truly is amazing and puts his whole heart into helping. He is extremely knowledgeable, and we knew we could trust him 100%. We live almost 3 hours away and Mott is worth the drive every time.” Hail, Gavin!

A new clinical trial will allow Michigan Medicine researchers to study 3D-printed bioresorbable devices aimed at treating children with rare and life-threatening airway condition tracheobronchomalacia. The trial, launched by Michigan Medicine and Materialise, marks a crucial step towards full FDA approval for the innovative devices designed to support the airways of infants with the severest forms of the disease. Tracheobronchomalacia causes the airway to collapse, making breathing difficult and, in severe cases, can be fatal. Currently, infants with this condition often rely on ventilators to survive. “We have established a process that allows us to offer the customized airway splint as a last resort treatment for certain children with no other options but we need more research to make it available on a wider scale,” said trial principal investigator Richard Ohye, M.D., a pediatric heart surgeon at U-M Health C.S. Mott Children’s Hospital, who leads surgical implantation of the device. “We needed a revolutionary innovation to give these babies a chance to survive,” said Mott otolaryngology surgeon Glenn Green, M.D., one of the inventors of the device. Learn more: michmed.org/Q98GZ

Vote for C.S. Mott Children's Hospital in STAT Madness - a "March Madness" for scientific discoveries! Mott scientists made it into this tournament for research uncovering the link between a common congenital viral infection and autism. The association highlights the importance of clinicians monitoring children with congenital cytomegalovirus, or CMV, for early signs of autism. You can help them advance to the next round by voting for them by Sunday night! Visit https://michmed.org/Stat25 to see the competitors and get a link to vote. All 8 U-M teams in STAT Madness this year received funding from the National Institutes of Health to fuel their discoveries and advances.

Meet Maria one of our Little Victors from our 2025 calendar. “In October 2019, Maria was diagnosed with an incredibly rare cancer known as anaplastic sarcoma of the kidney. With no established protocols for this rare cancer, the amazing team at C.S. Mott Children’s Hospital came together to create a multidisciplinary treatment plan, which included a left nephrectomy and numerous rounds of chemotherapy. Today, Maria is thriving in remission and radiates strength, humor and love—she’s truly the life of the party! Throughout her journey, her positivity and unwavering smile serves as a daily reminder of life’s beauty.” Hail, Maria!

?? ?? ?? Today is Rare Disease Day. Elle is among just 500 people in the world with an incurable neurodegenerative disease called BPAN. The devastating disease causes cognitive decline that increases with age, often leading to parkinsonism, dementia and intellectual disability. At Michigan Medicine, researchers are working to better understand BPAN and how to reverse its course. Elle's parents, Brian and Kaci Kegler, share their hopes for this research and what it could mean for families like theirs: https://michmed.org/jWkkz

??? The Save A Heart Silent Auction is LIVE! Bid on incredible items and experiences while creating hope for children with heart conditions. Every bid makes a difference! https://lnkd.in/gST5Tbgi